ATE331537T1 - Topisch anwendbare arzneimittelformulierung - Google Patents

Topisch anwendbare arzneimittelformulierung

Info

Publication number: ATE331537T1
Authority: AT; Austria
Prior art keywords: topically applicable; medicinal formulation; applicable medicinal; formulation; topically
Prior art date: 2001-07-24

Application number

AT02747591T

Other languages

English (en)

Inventor

Alvin Berlat

Original Assignee

Advanced Biotechnologies

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-24

Filing date

2002-07-23

Publication date

2006-07-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23190223&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE331537(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-07-23 Application filed by Advanced Biotechnologies filed Critical Advanced Biotechnologies

2006-07-15 Application granted granted Critical

2006-07-15 Publication of ATE331537T1 publication Critical patent/ATE331537T1/de

Links

239000000203 mixture Substances 0.000 title abstract 2
238000009472 formulation Methods 0.000 title 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
239000012530 fluid Substances 0.000 abstract 1
229910021485 fumed silica Inorganic materials 0.000 abstract 1
229920001296 polysiloxane Polymers 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
- A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Materials Engineering (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Inorganic Chemistry (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Dermatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT02747591T 2001-07-24 2002-07-23 Topisch anwendbare arzneimittelformulierung ATE331537T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US30754801P	2001-07-24	2001-07-24

Publications (1)

Publication Number	Publication Date
ATE331537T1 true ATE331537T1 (de)	2006-07-15

Family

ID=23190223

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02747591T ATE331537T1 (de)	2001-07-24	2002-07-23	Topisch anwendbare arzneimittelformulierung

Country Status (20)

Country	Link
US (1)	US8263114B2 (de)
EP (1)	EP1409034B1 (de)
JP (1)	JP3778559B2 (de)
KR (1)	KR101009267B1 (de)
CN (1)	CN1234426C (de)
AT (1)	ATE331537T1 (de)
AU (1)	AU2002317981B2 (de)
BR (1)	BRPI0211282B8 (de)
CA (1)	CA2454673C (de)
DE (1)	DE60212847T2 (de)
DK (1)	DK1409034T3 (de)
ES (1)	ES2268061T3 (de)
IL (2)	IL160109A0 (de)
MX (1)	MXPA04000444A (de)
NO (1)	NO334175B1 (de)
NZ (1)	NZ529957A (de)
PT (1)	PT1409034E (de)
RU (1)	RU2306121C2 (de)
WO (1)	WO2003009877A1 (de)
ZA (1)	ZA200400488B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070237834A1 (en) *	2003-04-18	2007-10-11	Bioderm Research	Zinc Zeolite for the Treatment for Diaper Rash (Diaper Dermatitis)
CA2530811C (en) *	2003-07-03	2013-01-08	The University Court Of The University Of St Andrews	Zeolites for delivery of nitric oxide
NZ555072A (en) *	2004-11-07	2010-09-30	Cupron Corp	Copper containing materials for treating wounds, burns and other skin conditions
WO2007085086A1 (en) *	2006-01-30	2007-08-02	Sanjeev Kaila	A composition including a silicone-based polymer and a method of treating skin disorders using the composition
WO2009003279A1 (en) *	2007-06-29	2009-01-08	Carmanah Technologies Corp.	Intelligent area lighting system
UA28103U (uk) *	2007-07-12	2007-11-26	Ольга Олександрівна Біляєва	Комплексний сорбційно-протеолітичний препарат сертасил для лікування гнійних ран, трофічних виразок, опіків
GB0821345D0 (en) *	2008-11-21	2008-12-31	P Q Silicas Uk Ltd	Composition and dressing with nitric oxide
WO2010079209A2 (en) *	2009-01-08	2010-07-15	Golub Alexandr A	Compositions for treating wounds and skin conditions
US20100322875A1 (en) *	2009-06-18	2010-12-23	Advanced Bio-Technologies, Inc.	Silicone scar treatment preparation
MX2012000827A (es) *	2009-07-17	2012-03-26	Carefusion 2200 Inc	Particulas que incorporan agentes antimicrobianos.
RU2429820C2 (ru) *	2009-09-24	2011-09-27	Закрытое акционерное общество "Институт прикладной нанотехнологии" (ЗАО"ИПН")	Антисептическая мазь наружного применения (2 варианта)
EP2496264A4 (de) *	2009-11-03	2014-03-26	Lipidor Ab	Zusammensetzung zur förderung der wundheilung
RU2578430C2 (ru) *	2009-11-03	2016-03-27	Липидор Аб	Композиция, образующая липидный слой, для нанесения на поверхность живого организма
US10500173B2 (en) *	2010-06-17	2019-12-10	Covalon Technologies Inc.	Antimicrobial silicone-based wound dressings
WO2012150890A1 (en) *	2011-05-02	2012-11-08	Lipidor Ab	Antibacterial composition
US20130144225A1 (en)	2011-12-06	2013-06-06	Jessica Rowen	Method And Device For Scar Management
TWI474823B (zh) *	2013-09-25	2015-03-01	Far Eastern New Century Corp	疤痕凝膠的組成物
US9226890B1 (en)	2013-12-10	2016-01-05	Englewood Lab, Llc	Polysilicone base for scar treatment
US11039620B2 (en)	2014-02-19	2021-06-22	Corning Incorporated	Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US9622483B2 (en)	2014-02-19	2017-04-18	Corning Incorporated	Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039621B2 (en)	2014-02-19	2021-06-22	Corning Incorporated	Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
CN106729963A (zh) *	2016-12-22	2017-05-31	苏州迈达医疗器械有限公司	一种硅酮凝胶敷料及其生产工艺
US10496949B2 (en)	2017-01-04	2019-12-03	Christopher Zoumalan	Compositions and methods for treating cutaneous conditions
RU2674445C1 (ru) *	2017-12-11	2018-12-10	Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия имени С.М. Кирова Министерства обороны Российской Федерации (ВМедА)	Спрей для наружного применения спиртовой
CN108714141A (zh) *	2018-05-29	2018-10-30	南京华开生物科技有限公司	硅酮疤痕喷剂
EP3827051A4 (de) *	2018-07-26	2022-03-02	Exciton Pharma Corp.	Fahrzeuge und abgabesysteme für oxidationsmittel
WO2020061671A1 (en) *	2018-09-26	2020-04-02	Exaltexx Inc.	Winterized maturing agent, viscosity reducer and production enhancer
US11433016B2 (en)	2019-03-28	2022-09-06	L'oreal	Cosmetic compositions for skin
US11207255B2 (en)	2019-07-30	2021-12-28	L'oreal	Perfluoro-free self-foaming facial cleanser composition
US11364190B2 (en)	2019-07-30	2022-06-21	L'oreal	Acid perfluoro-free self-foaming facial cleanser composition
US12109279B2 (en)	2020-08-25	2024-10-08	L'oreal	Self-bubbling peel-away cleansing mask
US11213473B1 (en)	2020-09-18	2022-01-04	Christopher Zoumalan	Skin brightening composition

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0618899B2 (ja) *	1987-06-30	1994-03-16	品川燃料株式会社	抗菌性ゼオライト含有フィルム
US5292530A (en) *	1991-06-02	1994-03-08	Helene Curtis, Inc.	Stable anhydrous topically-active composition and suspending agent therefor
JPH049327A (ja)	1990-04-04	1992-01-14	Kootec Kk	創傷被覆材
DE4034705A1 (de) *	1990-10-31	1992-05-07	Martin Neumann	Wundverschluss
FR2678513B1 (fr) *	1991-07-03	1995-06-30	Laboratoires Hygiene Dietetique	Pansement cicatrisant.
AU6525296A (en)	1995-07-19	1997-02-18	Innovative Technologies Limited	Wound treatment composition
US5833998A (en) *	1995-11-06	1998-11-10	The Procter & Gamble Company	Topical compositions for regulating the oily/shiny appearance of skin
JPH09194350A (ja)	1996-01-19	1997-07-29	Morishita Jintan Kk	創傷被覆材
US6231259B1 (en) *	1996-07-26	2001-05-15	The Gillette Company	Viscous product dispenser with porous dome
US5741509A (en) *	1996-08-26	1998-04-21	Alvin S. Berlat	Silicone wound dressing
WO1999030629A1 (en) *	1997-12-17	1999-06-24	Hemodynamics, Inc.	Sealing media for surgery and wound closure
US6183766B1 (en) *	1999-02-12	2001-02-06	The Procter & Gamble Company	Skin sanitizing compositions
CN1343114A (zh)	1999-02-12	2002-04-03	宝洁公司	皮肤卫生处理组合物
GB0007140D0 (en) *	1999-09-27	2000-05-17	Dow Corning Sa	Scar treatment composition
RU2002134482A (ru)	2000-05-23	2004-03-27	Унилевер Нв (Nl)	Композиции дезодоранта и/или антиперспиранта
US8486374B2 (en) *	2003-08-04	2013-07-16	Foamix Ltd.	Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20060110415A1 (en) *	2004-11-22	2006-05-25	Bioderm Research	Topical Delivery System for Cosmetic and Pharmaceutical Agents
US20080292560A1 (en) *	2007-01-12	2008-11-27	Dov Tamarkin	Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
BRPI0817607A2 (pt) *	2007-09-30	2014-10-14	Valeant Pharmaceuticals Int	Composições a base de gel de silicone para cicatrização de ferimentos e redução de cicatrizes.

2002
- 2002-07-23 PT PT02747591T patent/PT1409034E/pt unknown
- 2002-07-23 JP JP2003515269A patent/JP3778559B2/ja not_active Expired - Lifetime
- 2002-07-23 BR BRPI0211282A patent/BRPI0211282B8/pt not_active IP Right Cessation
- 2002-07-23 US US10/480,719 patent/US8263114B2/en active Active
- 2002-07-23 NZ NZ529957A patent/NZ529957A/en not_active IP Right Cessation
- 2002-07-23 CA CA2454673A patent/CA2454673C/en not_active Expired - Lifetime
- 2002-07-23 WO PCT/GB2002/003387 patent/WO2003009877A1/en not_active Ceased
- 2002-07-23 DE DE60212847T patent/DE60212847T2/de not_active Expired - Lifetime
- 2002-07-23 KR KR1020047001045A patent/KR101009267B1/ko not_active Expired - Lifetime
- 2002-07-23 DK DK02747591T patent/DK1409034T3/da active
- 2002-07-23 RU RU2004105164/15A patent/RU2306121C2/ru active
- 2002-07-23 AT AT02747591T patent/ATE331537T1/de active
- 2002-07-23 CN CNB028140214A patent/CN1234426C/zh not_active Expired - Lifetime
- 2002-07-23 IL IL16010902A patent/IL160109A0/xx active IP Right Grant
- 2002-07-23 ES ES02747591T patent/ES2268061T3/es not_active Expired - Lifetime
- 2002-07-23 EP EP02747591A patent/EP1409034B1/de not_active Expired - Lifetime
- 2002-07-23 MX MXPA04000444A patent/MXPA04000444A/es active IP Right Grant
- 2002-07-23 AU AU2002317981A patent/AU2002317981B2/en not_active Expired
2004
- 2004-01-22 ZA ZA2004/00488A patent/ZA200400488B/en unknown
- 2004-01-23 NO NO20040319A patent/NO334175B1/no not_active IP Right Cessation
- 2004-01-28 IL IL160109A patent/IL160109A/en unknown

Also Published As

Publication number	Publication date
KR101009267B1 (ko)	2011-01-18
WO2003009877A1 (en)	2003-02-06
NZ529957A (en)	2005-11-25
EP1409034B1 (de)	2006-06-28
CA2454673C (en)	2011-04-26
NO20040319L (no)	2004-01-23
RU2306121C2 (ru)	2007-09-20
AU2002317981B2 (en)	2006-12-07
CN1527729A (zh)	2004-09-08
ES2268061T3 (es)	2007-03-16
ZA200400488B (en)	2005-06-29
BR0211282B1 (pt)	2018-01-09
IL160109A0 (en)	2004-06-20
US20040234474A1 (en)	2004-11-25
US8263114B2 (en)	2012-09-11
NO334175B1 (no)	2014-01-06
KR20040032864A (ko)	2004-04-17
IL160109A (en)	2008-04-13
EP1409034A1 (de)	2004-04-21
BRPI0211282B8 (pt)	2021-05-25
DK1409034T3 (da)	2006-10-30
RU2004105164A (ru)	2005-06-27
HK1061362A1 (en)	2004-09-17
JP3778559B2 (ja)	2006-05-24
CA2454673A1 (en)	2003-02-06
BR0211282A (pt)	2004-08-03
DE60212847D1 (de)	2006-08-10
CN1234426C (zh)	2006-01-04
DE60212847T2 (de)	2007-06-14
JP2005502639A (ja)	2005-01-27
MXPA04000444A (es)	2004-10-27
PT1409034E (pt)	2006-11-30

Legal Events

Date

Code

Title

Description

2007-05-15

UEP

Publication of translation of european patent specification

Ref document number: 1409034

Country of ref document: EP

Publication	Publication Date	Title
DE60212847D1 (de)	2006-08-10	Topisch anwendbare arzneimittelformulierung
BR0107869A (pt)	2002-11-05	Composições farmacêuticas eletrogiradas
ID27504A (id)	2001-04-12	Formulasi oral baru
CL2009001279A1 (es)	2009-11-27	Compuestos derivados de nociceptina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor (sol. divisional 2103-03).
CL2008002406A1 (es)	2009-01-02	Composicion de pelicula de disolucion oral que comprende un agente activo cosmetico o farmaceutico, y un copolimero de injerto de poli(alcohol de vinilo)-polietilenglicol (divisional de la solicitud 1825-04).
DE60105448D1 (de)	2004-10-14	Feste dispersionen mit nitrataktiven wirkstoffen
ID22565A (id)	1999-11-11	Penggunaan nanodispersi dalam formulasi akhir obat
EE05383B1 (et)	2011-02-15	Polarlkarboksamiidhendid,ÁnendeÁvalmistamineÁjaÁkasutamineÁlipiiditasetÁalandavateÁtoimeainetenaÁningÁneidÁsisaldavÁfarmatseutilineÁkompositsioon
ATE460921T1 (de)	2010-04-15	Medikamenthaltige zusammensetzung in aerosolform
NO20024528L (no)	2002-11-19	Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
AU2002335046A1 (en)	2003-05-06	The use of proton sequestering agents in drug formulations
NO20040702L (no)	2004-05-19	Kombinerte preparater som inneholder 1,4-benzotiepin-1,1-dioksidderivater og andre aktive substanser og anvendelsen derav
ATE291914T1 (de)	2005-04-15	Zolmitriptanhaltige arzneizusammensetzungen
NO20011217D0 (no)	2001-03-09	Doseringsform omfattende væskeformulering
DE60019334D1 (de)	2005-05-12	Antivirale arznei
ATE302746T1 (de)	2005-09-15	Amorphe salpetersäureester und deren pharmazeutische zusammensetzungen
ATE301999T1 (de)	2005-09-15	Racecadotril enthaltende trockene pulverformulierung
NO20040055L (no)	2004-02-23	Sarbandasje
ATE314084T1 (de)	2006-01-15	Kahalalid f formulierung
PL402550A1 (pl)	2013-08-05	Dopochwowe kompozycje farmaceutyczne oraz zastosowanie zródla nadtlenku i bioadhezyjnego nosnika
DE60024476D1 (de)	2006-01-05	Pedikulizide und veterinärmedizinische zusammensetzungen
BR0108846A (pt)	2003-05-06	Formulação de oxazolidinona em comprimido
DE60111503D1 (de)	2005-07-21	Pharmazeutische zusammensetzungen enthaltend terbinafin
SE0001916D0 (sv)	2000-05-23	Novel formulation
NO20031650D0 (no)	2003-04-10	Nye legemidler for leversykdommer